Comparison | No. of participants (studies) | I2 (%) | GRADE | Relative effect (95% CI) | Anticipated absolute effects | ||
---|---|---|---|---|---|---|---|
Outcome | Risk with control | Risk difference with Cannabinoids | |||||
Chronic pain | Dronabinol vs Placebo | 1395 (15 RCTs) | 53 | ⨁⨁⨁◯ MODERATE c | SMD 0.31 lower (0.46 lower to 0.15 lower) | ||
Dronabinol vs Active | 14 (1 RCT) | SMD 0.73 higher (0.1 lower to 1.56 higher) | |||||
Nabilone vs Placebo | 363 (9 RCTs) | 70 | ⨁⨁◯◯ LOW c,g | SMD 0.41 lower (0.76 lower to 0.06 lower) | |||
Nabilone vs Active | 262 (3 RCTs) | 83 | ⨁◯◯◯ VERY LOW c,e | SMD 0.08 lower (0.54 lower to 0.38 higher) | |||
Cannabidiol vs Placebo | 129 (1 RCT) | SMD 0.01 higher (0.34 lower to 0.35 higher) | |||||
Nabiximols vs Placebo | 3238 (21 RCTs) | 65 | ⨁⨁⨁◯ MODERATE c | SMD 0.23 lower (0.34 lower to 0.12 lower) | |||
Spasticity | Dronabinol vs Placebo | 704 (6 RCTs) | 52 | ⨁⨁◯◯ LOW c,f | SMD 0.08 lower (0.34 lower to 0.17 higher) | ||
Nabilone vs Placebo | 44 (2 RCTs) | 68 | ⨁◯◯◯ VERY LOW a,c,g | SMD 0.7 lower (1.56 lower to 0.16 higher) | |||
Nabiximols vs Placebo | 1658 (14 RCTs) | 68 | ⨁⨁⨁◯ MODERATE c | SMD 0.36 lower (0.54 lower to 0.19 lower) | |||
Nausea/vomiting | Dronabinol vs Placebo | 495 (8 RCTs) | 61 | ⨁⨁◯◯ LOW c,f | SMD 0 .21 lower (0.49 lower to 0.07 higher) | ||
Dronabinol vs Active | 308 (5 RCTs) | 0 | ⨁⨁◯◯ LOW a,g | SMD 0.28 lower (0.47 lower to 0.1 lower) | |||
Nabilone vs Placebo | 603 (4 RCTs) | 61 | ⨁⨁◯◯ LOW c,f | SMD 0.09 lower (0.36 lower to 0.18 higher) | |||
Nabilone vs Active | 627 (11 RCTs) | 46 | ⨁⨁◯◯ LOW b,c | SMD 0.44 lower (0.62 lower to 0.26 lower) | |||
Nabiximols vs Placebo | 393 (6 RCTs) | 56 | ⨁◯◯◯ VERY LOW a,e | SMD 0.23 lower (0.55 lower to 0.08 higher) | |||
Appetite | Dronabinol vs Placebo | 599 (10 RCTs) | 81 | ⨁⨁⨁◯ MODERATE c | SMD 0.51 lower (0.87 lower to 0.15 lower) | ||
Dronabinol vs Active | 795 (3 RCTs) | 86 | ⨁⨁◯◯ LOW c,f | SMD 0.02 lower (0.39 lower to 0.34 higher) | |||
Nabilone vs Placebo | 187 (4 RCTs) | 74 | ⨁◯◯◯ VERY LOW c,e | SMD 0.44 lower (0.98 lower to 0.11 higher) | |||
Nabilone vs Active | 130 (3 RCTs) | 85 | ⨁◯◯◯ VERY LOW a,d, g | SMD 0.24 higher (0.51 lower to 0.99 higher) | |||
Cannabidiol vs Placebo | 27 (1 RCT) | SMD 0.1 higher (0.66 lower to 0.85 higher) | |||||
Nabiximols vs Placebo | 430 (6 RCTs) | 66 | ⨁⨁◯◯ LOW c,f | SMD 0.25 lower (0.61 lower to 0.1 higher) | |||
Amyotrophic lateral sclerosis | Dronabinol vs Placebo | 22 (1 RCT) | SMD 0.26 higher (0.17 lower to 0.68 higher) | ||||
Nabiximols vs Placebo | 59 (1 RCT) | SMD 0.38 higher (0.13 lower to 0.90 higher) | |||||
Chorea Huntington | Nabilone vs Placebo | 74 (1 RCT) | SMD 0.45 lower (0.79 lower to 0.11 lower) | ||||
Cannabidiol vs Placebo | 30 (1 RCT) | SMD 0.18 higher (0.33 lower to 0.69 higher) | |||||
Nabiximols vs Placebo | 50 (1 RCT) | SMD 0.17 higher (0.23 lower to 0.56 higher) | |||||
Dystonia | Dronabinol vs Placebo | 14 (1 RCT) | SMD 0.05 higher (0.69 lower to 0.79 higher) | ||||
Nabilone vs Placebo | 26 (1 RCT) | SMD 0.49 lower (1.07 lower to 0.08 higher) | |||||
Nabiximols vs Placebo | 50 (1 RCT) | SMD 0 (0.39 lower to 0.39 higher) | |||||
Epilepsy | Cannabidiol vs Placebo | 956 (6 RCTs) | 0 | ⨁⨁⨁⨁ HIGH | SMD 0.5 lower (0.62 lower to 0.38 lower) | ||
Glaucoma | Dronabinol vs Placebo | 12 (1 RCT) | SMD 1.28 lower (2.36 lower to 0.2 lower) | ||||
Nabiximols vs Placebo | 12 (1 RCT) | SMD 0.82 higher (0.1 lower to 1.75 higher) | |||||
IBS | Dronabinol vs Placebo | 81 (2 RCTs) | 85 | ⨁◯◯◯ VERY LOW c,e | SMD 0 (1.09 lower to 1.09 higher) | ||
MS | Dronabinol vs Placebo | 660 (2 RCTs) | 74 | ⨁⨁◯◯ LOW c,f | SMD 0.15 lower (0.51 lower to 0.22 higher) | ||
Nabiximols vs Placebo | 863 (5 RCTs) | 65 | ⨁⨁◯◯ LOW c,f | SMD 0.14 lower (0.38 lower to 0.11 higher) | |||
Parkinson | Nabilone vs Placebo | 51 (2 RCTs) | 46 | ⨁◯◯◯ VERY LOW c,e | SMD 0.38 lower (1.05 lower to 0.29 higher) | ||
Cannabidiol vs Placebo | 101 (3 RCTs) | 0 | ⨁⨁⨁◯ MODERATE g | SMD 0.41 lower (0.75 lower to 0.08 lower) | |||
ADHD | Nabiximols vs Placebo | 30 (1 RCT) | SMD 0.83 lower (1.58 lower to 0.09 lower) | ||||
Anorexia nervosa | Dronabinol vs Placebo | 48 (1 RCT) | SMD 0.47 lower (0.89 lower to 0.05 lower) | ||||
Dronabinol vs Active | 22 (1 RCT) | SMD 0.06 lower (0.65 lower to 0.53 higher) | |||||
Anxiety | Dronabinol vs Placebo | 113 (4 RCTs) | 49 | ⨁⨁◯◯ LOW e | SMD 0.03 lower (0.47 lower to 0.41 higher) | ||
Dronabinol vs Active | 278 (1 RCT) | SMD 0.14 higher (0.03 lower to 0.31 higher) | |||||
Nabilone vs Placebo | 147 (6 RCTs) | 84 | ⨁◯◯◯ VERY LOW a,c,e | SMD 0.59 lower (1.4 lower to 0.22 higher) | |||
Nabilone vs Active | 192 (2 RCTs) | 11 | ⨁⨁◯◯ LOW e | SMD 0.11 lower (0.33 lower to 0.11 higher) | |||
Cannabidiol vs Placebo | 481 (11 RCTs) | 78 | ⨁◯◯◯ VERY LOW c,e | SMD 0.34 lower (0.73 lower to 0.06 higher) | |||
Nabiximols vs Placebo | 258 (6 RCTs) | 43 | ⨁⨁◯◯ LOW e | SMD 0.06 higher (0.23 lower to 0.34 higher) | |||
Dementia | Dronabinol vs Placebo | 115 (3 RCTs) | 3 | ⨁⨁◯◯ LOW e | SMD 0.27 lower (0.57 lower to 0.04 higher) | ||
Nabilone vs Placebo | 76 (1 RCT) | SMD 0.53 lower (0.87 lower to 0.19 lower) | |||||
Depression | Dronabinol vs Placebo | 700 (7 RCTs) | 83 | ⨁⨁◯◯ LOW c,f | SMD 0.15 lower (0.49 lower to 0.19 higher) | ||
Dronabinol vs Active | 278 (1 RCT) | SMD 0.14 higher (0.03 lower to 0.31 higher) | |||||
Nabilone vs Placebo | 76 (3 RCTs) | 0 | ⨁⨁◯◯ LOW e | SMD 0.03 lower (0.48 lower to 0.43 higher) | |||
Nabilone vs Active | 192 (2 RCTs) | 0 | ⨁⨁◯◯ LOW e | SMD 0.03 lower (0.23 lower to 0.17 higher) | |||
Cannabidiol vs Placebo | 301 (6 RCTs) | 0 | ⨁⨁◯◯ LOW e | SMD 0.12 higher (0.09 lower to 0.34 higher) | |||
Nabiximols vs Placebo | 413 (7 RCTs) | 43 | ⨁⨁⨁◯ MODERATE f | SMD 0.12 lower (0.36 lower to 0.13 higher) | |||
PTSD | Dronabinol vs Placebo | 46 (1 RCT) | SMD 0.63 lower (1.22 lower to 0.03 lower) | ||||
Nabilone vs Placebo | 18 (1 RCT) | SMD 0.88 lower (1.65 lower to 0.11 lower) | |||||
Schizophrenia /psychosis | Dronabinol vs Placebo | 26 (1 RCT) | SMD 0.89 higher (0.25 higher to 1.53 higher) | ||||
Cannabidiol vs Placebo | 152 (3 RCTs) | 70 | ⨁◯◯◯ VERY LOW c,f | SMD 0.24 lower (0.81 lower to 0.33 higher) | |||
Cannabidiol vs Active | 39 (1 RCT) | SMD 0.05 higher (0.58 lower to 0.68 higher) | |||||
Sleep | Dronabinol vs Placebo | 683 (7 RCTs) | 64 | ⨁⨁◯◯ LOW c,f | SMD 0.13 lower (0.39 lower to 0.12 higher) | ||
Dronabinol vs Active | 22 (1 RCT) | SMD 1.12 higher (0.37 higher to 1.87 higher) | |||||
Nabilone vs Placebo | 175 (6 RCTs) | 77 | ⨁◯◯◯ VERY LOW c,g | SMD 0.58 lower (1.14 lower to 0.01 lower) | |||
Nabilone vs Active | 200 (2 RCTs) | 91 | ⨁◯◯◯ VERY LOW d,e | SMD 0.21 lower (0.97 lower to 0.55 higher) | |||
Cannabidiol vs Placebo | 961 (8 RCTs) | 46 | ⨁⨁◯◯ LOW a,c | SMD 0.06 lower (0.23 lower to 0.11 higher) | |||
Nabiximols vs Placebo | 3659 (23 RCTs) | 61 | ⨁⨁⨁◯ MODERATE c | SMD 0.24 lower (0.35 lower to 0.14 lower) | |||
SUDs | Dronabinol vs Placebo | 196 (3 RCTs) | 0 | ⨁⨁◯◯ LOW a,g | SMD 0.47 lower (0.73 lower to 0.2 lower) | ||
Dronabinol vs Active | 60 (1 RCT) | SMD 0.85 lower (1.41 lower to 0.29 lower) | |||||
Nabilone vs Placebo | 70 (3 RCTs) | 0 | ⨁⨁◯◯ LOW a,g | SMD 0.55 lower (0.93 lower to 0.18 lower) | |||
Cannabidiol vs Placebo | 353 (7 RCTs) | 81 | ⨁◯◯◯ VERY LOW c,e | SMD 0.2 lower (0.63 lower to 0.24 higher) | |||
Nabiximols vs Placebo | 237 (4 RCTs) | 59 | ⨁⨁⨁◯ MODERATE g | SMD 0.48 lower (0.92 lower to 0.04 lower) | |||
Tourette | Dronabinol vs Placebo | 41 (2 RCTs) | 0 | ⨁⨁⨁◯ MODERATE g | SMD 1.01 lower (1.58 lower to 0.44 lower) | ||
Retention | Dronabinol vs Placebo | 3285 (37 RCTs) | 65 | ⨁⨁◯◯ LOW c,f | OR 1.11 (0.80 to 1.53) | 194 per 1.000 | 17 more per 1.000 (33 fewer to 75 more) |
Dronabinol vs Active | 1079 (8 RCTs) | 32 | ⨁◯◯◯ VERY LOW a,e | OR 1.03 (0.76 to 1.40) | 422 per 1.000 | 7 more per 1.000 (65 fewer to 83 more) | |
Nabilone vs Placebo | 1070 (16 RCTs) | 0 | ⨁◯◯◯ VERY LOW a,e | OR 0.99 (0.76 to 1.29) | 143 per 1.000 | 1 fewer per 1.000 (30 fewer to 34 more) | |
Nabilone vs Active | 1004 (13 RCTs) | 0 | ⨁◯◯◯ VERY LOW a,e | OR 0.99 (0.79 to 1.25) | 205 per 1.000 | 2 fewer per 1.000 (36 fewer to 39 more) | |
Cannabidiol vs Placebo | 1775 (22 RCTs) | 41 | ⨁◯◯◯ VERY LOW c,g | OR 1.38 (0.77 to 2.47) | 71 per 1.000 | 24 more per 1.000 (15 fewer to 88 more) | |
Nabiximols vs Placebo | 4643 (33 RCTs) | 44 | ⨁⨁◯◯ LOW c,f | OR 1.17 (0.92 to 1.49) | 170 per 1.000 | 23 more per 1.000 (11 fewer to 64 more) | |
Adverse events | Dronabinol vs Placebo | 2707 (37 RCTs) | 56 | ⨁⨁◯◯ LOW c | OR 2.16 (1.59 to 2.94) | 320 per 1.000 | 184 more per 1.000 (108 more to 260 more) |
Dronabinol vs Active | 925 (8 RCTs) | 67 | ⨁⨁◯◯ LOW a,c | OR 2.75 (1.43 to 5.26) | 466 per 1.000 | 240 more per 1.000 (89 more to 355 more) | |
Nabilone vs Placebo | 996 (16 RCTs) | 76 | ⨁⨁⨁◯ MODERATE c | OR 3.12 (1.52 to 6.42) | 226 per 1.000 | 251 more per 1.000 (81 more to 426 more) | |
Nabilone vs Active | 909 (13 RCTs) | 71 | ⨁⨁◯◯ LOW a,c | OR 2.47 (1.45 to 4.20) | 223 per 1.000 | 192 more per 1.000 (71 more to 324 more) | |
Cannabidiol vs Placebo | 1736 (22 RCTs) | 58 | ⨁⨁⨁◯ MODERATE c | OR 1.82 (1.08 to 3.07) | 482 per 1.000 | 147 more per 1.000 (19 more to 259 more) | |
Nabiximols vs Placebo | 4404 (33 RCTs) | 74 | ⨁⨁⨁◯ MODERATE c | OR 1.97 (1.48 to 2.64) | 536 per 1.000 | 159 more per 1.000 (95 more to 217 more) |